Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine in Alcohol Use Disorders
NCT03764098Phase 2Recruiting
- Sponsor
- Yale University
- Start
- Aug 2020
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of guanfacine in alcohol use disorder (AUD), sponsored by Yale University. Started Aug 2020; status: recruiting.
02
Drugs
guanfacine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03764098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03764098.